Seoulin Bioscience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	10,849	10,452	8,949	14,602	8,999	14,973
Short-Term Investments	22,958	22,256	14,467	20,722	41,319	40,360
Trading Asset Securities	1,017	2,008	93.22	90.3	4,962	19,999
Cash & Short-Term Investments	34,823	34,716	23,510	35,414	55,280	75,332
Cash Growth	58.38%	47.67%	-33.62%	-35.94%	-26.62%	279.32%
Accounts Receivable	7,918	8,121	7,323	12,986	6,652	10,137
Other Receivables	524.05	408.81	528.24	1,291	630.36	196.33
Receivables	8,442	8,529	7,851	14,294	7,282	10,333
Inventory	24,250	24,721	26,245	21,785	17,307	13,933
Prepaid Expenses	40.54	33.28	13.63	53.74	51.32	32.59
Other Current Assets	5,607	4,035	2,222	1,408	7,366	5,352
Total Current Assets	73,163	72,035	59,841	72,955	87,287	104,983
Property, Plant & Equipment	16,847	16,839	16,628	18,914	16,491	14,937
Long-Term Investments	24,437	24,928	19,460	17,512	25,555	7,515
Goodwill	-	-	373.89	526.49	526.49	526.49
Other Intangible Assets	349.3	359.98	395.06	425.08	266.64	230.54
Long-Term Deferred Tax Assets	2,100	2,098	2,222	2,259	1,269	2,766
Long-Term Deferred Charges	60.11	69.65	107.82	156.08	210.96	558.01
Other Long-Term Assets	2,461	2,469	2,496	1,335	3,840	5,051
Total Assets	119,417	118,798	101,525	114,100	135,486	136,566
Accounts Payable	6,157	7,543	5,009	11,428	8,603	10,888
Accrued Expenses	1,374	477.01	390.22	387.97	373.05	329.11
Short-Term Debt	11,756	11,422	3,450	6,120	17,469	15,259
Current Portion of Long-Term Debt	-	-	-	-	62.5	256.25
Current Portion of Leases	79.35	95.56	156.68	271.44	69.22	34.65
Current Income Taxes Payable	22.49	-	-	700.11	730.13	4,561
Other Current Liabilities	13,391	12,132	4,628	9,122	19,058	28,112
Total Current Liabilities	32,780	31,669	13,634	28,030	46,365	59,440
Long-Term Debt	-	-	-	98.6	98.47	154.85
Long-Term Leases	49.16	62.61	73.29	224.29	86.11	32.85
Pension & Post-Retirement Benefits	764.56	537.63	478.96	254.11	-	285.87
Other Long-Term Liabilities	483.07	476.95	465.66	253.48	151.59	150
Total Liabilities	34,077	32,746	14,652	28,861	46,701	60,064
Common Stock	4,650	4,550	4,450	4,350	4,250	4,150
Additional Paid-In Capital	18,921	18,921	18,519	18,519	18,519	18,490
Retained Earnings	68,290	69,090	69,170	67,177	68,475	58,805
Treasury Stock	-4,555	-4,555	-4,496	-3,404	-3,261	-3,062
Comprehensive Income & Other	-3,795	-3,795	-3,751	-3,581	-3,581	-3,523
Total Common Equity	83,511	84,211	83,893	83,063	84,403	74,861
Minority Interest	1,829	1,841	2,980	2,177	4,382	1,642
Shareholders' Equity	85,340	86,052	86,872	85,239	88,785	76,502
Total Liabilities & Equity	119,417	118,798	101,525	114,100	135,486	136,566
Total Debt	11,885	11,580	3,680	6,714	17,785	15,738
Net Cash (Debt)	22,939	23,137	19,830	28,700	37,495	59,594
Net Cash Growth	7.20%	16.68%	-30.91%	-23.46%	-37.08%	211.92%
Net Cash Per Share	2376.24	2400.48	2279.74	3201.94	3369.03	6625.03
Filing Date Shares Outstanding	8.82	8.63	8.63	8.76	8.77	8.77
Total Common Shares Outstanding	8.82	8.63	8.96	8.97	8.98	8.99
Working Capital	40,383	40,366	46,207	44,924	40,922	45,543
Book Value Per Share	9469.79	9761.49	9363.40	9262.33	9398.97	8324.26
Tangible Book Value	83,162	83,851	83,124	82,111	83,610	74,104
Tangible Book Value Per Share	9430.18	9719.76	9277.57	9156.22	9310.65	8240.08
Land	4,074	4,074	3,967	4,246	3,721	3,185
Buildings	11,114	11,204	11,263	12,539	11,192	10,642
Machinery	1,419	1,281	1,026	1,474	1,193	851.95
Construction In Progress	-	-	-	-	6	-